Correlation Between Bavarian Nordic and Ascelia Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bavarian Nordic and Ascelia Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bavarian Nordic and Ascelia Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bavarian Nordic and Ascelia Pharma AB, you can compare the effects of market volatilities on Bavarian Nordic and Ascelia Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bavarian Nordic with a short position of Ascelia Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bavarian Nordic and Ascelia Pharma.

Diversification Opportunities for Bavarian Nordic and Ascelia Pharma

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bavarian and Ascelia is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Bavarian Nordic and Ascelia Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascelia Pharma AB and Bavarian Nordic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bavarian Nordic are associated (or correlated) with Ascelia Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascelia Pharma AB has no effect on the direction of Bavarian Nordic i.e., Bavarian Nordic and Ascelia Pharma go up and down completely randomly.

Pair Corralation between Bavarian Nordic and Ascelia Pharma

Assuming the 90 days trading horizon Bavarian Nordic is expected to generate 988.0 times less return on investment than Ascelia Pharma. In addition to that, Bavarian Nordic is 1.3 times more volatile than Ascelia Pharma AB. It trades about 0.0 of its total potential returns per unit of risk. Ascelia Pharma AB is currently generating about 0.35 per unit of volatility. If you would invest  255.00  in Ascelia Pharma AB on September 13, 2024 and sell it today you would earn a total of  78.00  from holding Ascelia Pharma AB or generate 30.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bavarian Nordic  vs.  Ascelia Pharma AB

 Performance 
       Timeline  
Bavarian Nordic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bavarian Nordic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Ascelia Pharma AB 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ascelia Pharma AB are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating technical and fundamental indicators, Ascelia Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bavarian Nordic and Ascelia Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bavarian Nordic and Ascelia Pharma

The main advantage of trading using opposite Bavarian Nordic and Ascelia Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bavarian Nordic position performs unexpectedly, Ascelia Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascelia Pharma will offset losses from the drop in Ascelia Pharma's long position.
The idea behind Bavarian Nordic and Ascelia Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.